The top companies in med tech: 2015 revenue results


Med tech companies have found only one reliable way to boost sales–that’s to buy them. The only players with sizable sales increases last year were driven by major acquisitions, according to data from Evaluate Medtech.* In fact, only two of the 10 companies as ranked by medical device and diagnostics sales actually had positive sales growth without an acquisition.

Medtronic ($MDT) made the biggest sales gains on the back of its $43 billion acquisition of Covidien–with sales up 43%. Meanwhile, Becton Dickinson’s $12 billion buy of CareFusion boosted its sales by 26% last year.

Orthopedics player Stryker ($SYK) fared the best without a big deal on growing sales. But it only grew by 3% to almost $10 billion. Royal Philips ($PHG) eked out a 1% increase on its med tech sales–but it’s committed to doing better as it sheds its lighting businesses and devotes itself entirely to HealthTech.


About Peter Coffaro 1148 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.